Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.65% |
| 3 | Consumer Staples | 12.19% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Verra Mobility
VRRM
$852M
| $2.67M | ﹤0.01% |
276,100
-79,500
| -22% | -$831K |
|
1952
LXP Industrial Trust
LXP
$3.56B
| $2.66M | ﹤0.01% |
+50,976
| New | +$2.83M |
|
1953
Ternium
TX
$9.76B
| $2.66M | ﹤0.01% |
+141,400
| New | +$2.37M |
|
|
PW
1954
Power REIT
PW
$2.81M
| $2.66M | ﹤0.01% |
13,430
-820
| -6% | -$190K |
|
1955
Townsquare Media
TSQ
$109M
| $2.66M | ﹤0.01% |
570,952
+3,300
| +0.6% | +$15.3K |
|
1956
Option Care Health
OPCH
$3.55B
| $2.66M | ﹤0.01% |
198,906
+45,930
| +30% | +$558K |
|
1957
Diodes
DIOD
$3.77B
| $2.66M | ﹤0.01% |
+47,051
| New | +$2.38M |
|
1958
MarineMax
HZO
$774M
| $2.65M | ﹤0.01% |
103,400
+92,100
| +815% | +$2.53M |
|
1959
Reading International Class A
RDI
$32.7M
| $2.65M | ﹤0.01% |
824,090
-10,700
| -1% | -$43.5K |
|
1960
Prothena Corp
PRTA
$436M
| $2.65M | ﹤0.01% |
265,200
-122,762
| -32% | -$1.48M |
|
1961
Axalta
AXTA
$7.76B
| $2.65M | ﹤0.01% |
119,377
-1,278,900
| -91% | -$29.6M |
|
1962
ASE Group
ASX
$80.7B
| $2.64M | ﹤0.01% |
647,638
-559,762
| -46% | -$2.5M |
|
1963
TG Therapeutics
TGTX
$7.07B
| $2.64M | ﹤0.01% |
98,600
-1,056,800
| -91% | -$24.3M |
|
1964
Apyx Medical
APYX
$176M
| $2.64M | ﹤0.01% |
559,795
-22,400
| -4% | -$111K |
|
1965
CMS Energy
CMS
$22.5B
| $2.63M | ﹤0.01% |
42,900
-599,594
| -93% | -$36.7M |
|
1966
Crown Crafts
CRWS
$31.7M
| $2.63M | ﹤0.01% |
466,208
+20,200
| +5% | +$107K |
|
1967
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $2.63M | ﹤0.01% |
+64,400
| New | +$2.64M |
|
|
SURF
1968
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $2.63M | ﹤0.01% |
381,737
-177,600
| -32% | -$1.08M |
|
1969
Itron
ITRI
$4.42B
| $2.63M | ﹤0.01% |
+43,261
| New | +$2.75M |
|
1970
Celestica
CLS
$39.3B
| $2.62M | ﹤0.01% |
+380,088
| New | +$2.86M |
|
1971
Citizens & Northern Corp
CZNC
$454M
| $2.62M | ﹤0.01% |
161,500
-21,400
| -12% | -$377K |
|
1972
Agios Pharmaceuticals
AGIO
$1.82B
| $2.62M | ﹤0.01% |
+74,800
| New | +$3.28M |
|
|
SUNE
1973
SUNation Energy
SUNE
$9.65M
| $2.61M | ﹤0.01% |
1
| – | – |
|
|
MPX
1974
DELISTED
Marine Products Corp
MPX
| $2.61M | ﹤0.01% |
166,702
-50,200
| -23% | -$774K |
|
1975
Hurco Companies Inc
HURC
$142M
| $2.6M | ﹤0.01% |
91,700
-9,500
| -9% | -$276K |
|
Similar funds
Renaissance Technologies's Q3 2020 Portfolio in Review
As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.
- Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
- Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.